These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9143859)

  • 1. Neuro-psychiatric effects of antimalarials.
    van Riemsdijk MM; van der Klauw MM; van Heest JA; Reedeker FR; Ligthelm RJ; Herings RM; Stricker BH
    Eur J Clin Pharmacol; 1997; 52(1):1-6. PubMed ID: 9143859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis.
    Hoebe C; de Munter J; Thijs C
    Eur J Clin Pharmacol; 1997; 52(4):269-75. PubMed ID: 9248763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
    Barrett PJ; Emmins PD; Clarke PD; Bradley DJ
    BMJ; 1996 Aug; 313(7056):525-8. PubMed ID: 8789977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
    Phillips-Howard PA; Steffen R; Kerr L; Vanhauwere B; Schildknecht J; Fuchs E; Edwards R
    J Travel Med; 1998 Sep; 5(3):121-6. PubMed ID: 9772329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial.
    Croft AM; Clayton TC; World MJ
    Trans R Soc Trop Med Hyg; 1997; 91(2):199-203. PubMed ID: 9196769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
    Steffen R; Fuchs E; Schildknecht J; Naef U; Funk M; Schlagenhauf P; Phillips-Howard P; Nevill C; Stürchler D
    Lancet; 1993 May; 341(8856):1299-303. PubMed ID: 8098447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.
    Meier CR; Wilcock K; Jick SS
    Drug Saf; 2004; 27(3):203-13. PubMed ID: 14756582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.
    Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO
    J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse effects associated with antimalarial chemoprophylaxis].
    Corominas N; Gascón J; Mejías T; Caparrós F; Quintó L; Codina C; Ribas J; Corachán M
    Med Clin (Barc); 1997 May; 108(20):772-5. PubMed ID: 9265081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilisation of malaria prophylaxis: the effect of changes in guidelines in The Netherlands, 1993-1998.
    van Riemsdijk MM; Sturkenboom MC; Schilthuis HJ; Stricker BH
    Pharm World Sci; 2003 Feb; 25(1):21-4. PubMed ID: 12661472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Wolters BA; Bosje T; Luinstra-Passchier MJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):331-4. PubMed ID: 9132607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study.
    Schlagenhauf P; Johnson R; Schwartz E; Nothdurft HD; Steffen R
    J Travel Med; 2009; 16(1):42-5. PubMed ID: 19192127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events.
    van Riemsdijk MM; Sturkenboom MC; Ditters JM; Ligthelm RJ; Overbosch D; Stricker BH
    Clin Pharmacol Ther; 2002 Sep; 72(3):294-301. PubMed ID: 12235450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria at Christmas: risks of prophylaxis versus risks of malaria.
    Reid AJ; Whitty CJ; Ayles HM; Jennings RM; Bovill BA; Felton JM; Behrens RH; Bryceson AD; Mabey DC
    BMJ; 1998 Nov; 317(7171):1506-8. PubMed ID: 9831584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands.
    van Riemsdijk MM; Sturkenboom MC; Pepplinkhuizen L; Stricker BH
    J Clin Psychiatry; 2005 Feb; 66(2):199-204. PubMed ID: 15705005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
    Kofoed K; Petersen E
    J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.